Current consensus is that GLP-1 treatment benefits outweigh the risk of EWDR: the drugs reduce the risk of further microvascular damage from poor glycemic control and reduce the chance of death from cardiovascular disease, while the impact on DR is short-lived and can be treated
PMID: 273 CampbellPJGetzGKorbelJOStuartJMJenningsJLSteinLDet al
GLP-1 medicines may have anti-inflammatory effects Researchers are also studying whether GLP-1 medicines may directly affect immune cells and inflammatory pathways
Ja, es wird hufig in gemeinschaftlicher Forschung verwendet, aber es ist wichtig, die Wirkung auf die REM-Phase zu beobachten
After an additional 4 days ( t = 96 h), cells were collected by trypsinization, pelleted, snap-frozen and stored at 80 C
Our commitment to excellent patient care remains our top priority